News Feature Channel: Pharmaceuticals

A Breakthrough Moment: McMaster Researchers Discover New Class of Antibiotics

McMaster University — Wed, 26 Mar 2025 12:00:00 EST

A McMaster University team led by renowned researcher Gerry Wright has identified a strong candidate to challenge even some of the most drug-resistant bacteria on the planet: a new molecule called lariocidin.

A Review of Latest Tools and Technologies in Pharmaceutical Research

Chinese Academy of Sciences — Wed, 26 Mar 2025 09:35:21 EST

This comprehensive review analyzes cutting-edge tools and technologies in modern pharmaceutical research, focusing on artificial intelligence, multi-omics technologies, and experimental methods. The study highlights how computational methods enhance drug discovery efficiency, while omics technologies provide systematic frameworks for investigating drug mechanisms. The integration of these advanced approaches has enabled more diverse and personalized treatment strategies, though challenges remain in drug development complexity, cost-effectiveness, and operational feasibility.

Blue Pigment Improves Foundation Makeup Shades for Dark Skin

American Chemical Society (ACS) — Wed, 26 Mar 2025 05:00:00 EST

Darker makeup foundations often fall flat, appearing gray-like once applied on the skin. But now, researchers report a blue cosmetic color additive that gives darker foundations the warmth and depth that current formulations lack. They will present their results at ACS Spring 2025.

El pigmento azul mejora el tono de las bases de maquillaje para pieles oscuras

American Chemical Society (ACS) — Wed, 26 Mar 2025 05:00:00 EST

Las bases de maquillaje mas oscuras suelen fallar de plano, ya que dan un aspecto grisaceo al aplicarlas sobre la piel. Pero ahora, los investigadores informan de un aditivo de color azul para cosmeticos que proporciona a las bases mas oscuras la calidez e intensidad de las que carecen las formulas actuales. Presentaran sus resultados en el encuentro de primavera de 2025 de la ACS.

Phenomenex Introduces Biozen(tm) Native RP-1 and RP-5: A Novel Way to Characterize ADCs with Unmatched Throughput and High-Quality Data

Phenomenex — Tue, 25 Mar 2025 19:25:29 EST

Phenomenex Introduces Biozen(tm) Native RP-1 and RP-5: A Novel Way to Characterize ADCs with Unmatched Throughput and High-Quality Data

Ibuprofen Inhibits Human Sweet Taste and Glucose Detection by Taste Cells, According to Monell Center Study

Monell Chemical Senses Center — Tue, 25 Mar 2025 08:55:06 EST

A team from the Monell Chemical Senses Center and Rutgers University have published a study in the British Journal of Pharmacology that indicates anti-inflammatory medications like ibuprofen and naproxen could be another way to reduce the risk of metabolic diseases by inhibiting the sweet taste receptor throughout the body.

Silk Sponges Instead of Animal Testing: How a 3D Cell Culture System Could Revolutionize Cancer Diagnostics

University of Vienna — Fri, 21 Mar 2025 05:00:34 EST

An FFG-funded consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien together with company partner DOC Medikus GmbH has developed an innovative bioanalytical test system for radiopharmaceutical drug candidates for cancer diagnosis and therapy. It does not require any animal testing at all and enables automated, fast and highly precise analyses. The new method was presented in detail in the renowned Journal of Nuclear Medicine.

UTEP Researchers Test New, More Reliable Method to Detect Chagas Disease

University of Texas at El Paso — Thu, 20 Mar 2025 18:20:11 EST

Researchers at The University of Texas at El Paso have successfully tested a faster, more sensitive and reliable way to diagnose Chagas disease, a debilitating parasitic illness that affects approximately 6 million people worldwide. The results of the new study were recently published in the International Journal of Molecular Sciences.

To Overcome Antibiotic Resistance, New Research Says to Let It Flow

College of Liberal Arts and Sciences, University of Illinois Urbana-Champaign — Thu, 20 Mar 2025 18:15:36 EST

Some notoriously difficult to treat infections may not be as resistant to antibiotics as has been thought, according to University of Illinois research using a microfluidic device that more closely duplicates the fluid flow found in the body.

Alliance for Genomic Discovery Completes 250,000 Whole Genomes to Accelerate Drug Discovery

Vanderbilt University Medical Center — Thu, 20 Mar 2025 10:35:43 EST

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc. today announced that 250,000 whole genomes have been sequenced for the Alliance for Genomic Discovery (AGD) initiative. Insights from the AGD database are being leveraged to accelerate drug target discovery, therapeutic research and clinical development.

Study Highlights Need for Greater Regulation of Antibiotics Entering Freshwater Environments

Toronto Metropolitan University — Wed, 19 Mar 2025 10:00:00 EST

Pharmaceutical chemicals entering waterways can have long-term consequences for aquatic, human and environmental health. Researcher Joseph Aladekoyi is studying the impact of pharmaceutical drugs entering freshwater ecosystems.

Rutgers Names Director of Center for Pharmacoepidemiology and Treatment Science at Institute for Health

Tue, 18 Mar 2025 21:10:18 EST

Rutgers Names Director of Center for Pharmacoepidemiology and Treatment Science at Institute for Health

Liver Supplements - Hype or Harm?

Hackensack Meridian Health — Tue, 18 Mar 2025 09:10:53 EST

Social Prescribing, a New Way of Promoting Psycho-Physical Well-Being and Healing Through Social Contacts

Universita Cattolica del Sacro Cuore — Tue, 18 Mar 2025 06:00:00 EST

Social Prescribing, a new way of promoting psycho-physical well-being and healing through social contacts.

VAS101, a Novel Curcumin Transdermal Formulation, Reverses Some Clinical Hallmarks of Aging

Vascarta Inc. — Mon, 17 Mar 2025 18:10:03 EST

VAS101, a Novel Curcumin Transdermal Formulation, Reverses Some Clinical Hallmarks of Aging

New ACP Guideline Recommends Combination Therapy for Acute Episodic Migraines

American College of Physicians (ACP) — Mon, 17 Mar 2025 17:00:00 EST

The American College of Physicians (ACP) has developed new recommendations for treatment of acute episodic migraines in nonpregnant adults in outpatient settings.

iOncologi, Inc. Announces the Appointment of Dr. Mona Flores and Mr. Paolo Fundaro to Its Board of Directors

iOncologi, Inc. — Mon, 17 Mar 2025 06:20:56 EST

iOncologi, Inc. (www.ioncologi.com), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for cancer treatment, today announced the appointment of Dr. Mona Flores and Mr. Paolo Fundaro to its Board of Directors.

Two NJIT Faculty Elected as National Academy of Inventors Senior Members

New Jersey Institute of Technology (NJIT) — Fri, 14 Mar 2025 20:15:02 EST

New Jersey Institute of Technology Professors Vivek Kumar and Xuan Liu have been named as Senior Members in the National Academy of Inventors (NAI) 2025 class. They join 162 emerging academic inventors from 64 NAI Member Institutions across the nation recognized for their outstanding contributions to innovation.

WashU Experts: What Walgreens' $10 Billion Private Equity Deal Means for Consumers, Pharmacy Industry

Washington University in St. Louis — Thu, 13 Mar 2025 21:15:49 EST

After years of financial turmoil, Walgreens recently announced that it has reached a $10 billion buyout deal with private-equity firm Sycamore -- a move that likely will have wide-ranging consequences for how consumers access health care and health-care products, according to Washington University in St. Louis experts Patrick Aguilar and Peter Boumgarden.

FASEB Announces Inaugural Cohort of Fellows for the Future Program

Federation of American Societies for Experimental Biology (FASEB) — Wed, 12 Mar 2025 19:35:37 EST

FASEB welcomes the inaugural Fellows for the Future cohort, supporting early-career researchers from historically excluded groups who are dedicated to promoting inclusion in scientific societies.